Back
WisdomTree US Quality Dividend Growth Fund Vs. Structure Therapeutics, Inc. Industry Stock Comparison
Buy
69
DGRW
WisdomTree US Quality Dividend Growth Fund
Last Price:
$90.41
Seasonality Move:
0.59%
Buy
63
GPCR
Structure Therapeutics, Inc.
Last Price:
$69.39
Seasonality Move:
-34.19%
Buy
69
WisdomTree US Quality Dividend Growth Fund (DGRW)
is a Buy
Is WisdomTree US Quality Dividend Growth Fund a Buy, Sell or Hold?
-
The current WisdomTree US Quality Dividend Growth Fund [DGRW] share price is $89.93. The Score for DGRW is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
-
DGRW is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
63
Structure Therapeutics, Inc. (GPCR)
is a Buy
Is Structure Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Structure Therapeutics, Inc. [GPCR] share price is $71.29. The Score for GPCR is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
-
GPCR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
DGRW Stock Price Chart
What is WisdomTree US Quality Dividend Growth Fund's stock price today?
-
The WisdomTree US Quality Dividend Growth Fund share price today is $89.93Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DGRW is experiencing buying pressure, which is a positive indicator for future bullish movement.
GPCR Stock Price Chart
What is Structure Therapeutics, Inc.'s stock price today?
-
The Structure Therapeutics, Inc. share price today is $71.29Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GPCR is experiencing buying pressure, which is a positive indicator for future bullish movement.
DGRW Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.12 | Buy |
| Relative Strength Index (14 RSI): | 56.17 | Buy |
| Chaikin Money Flow: | 306077 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (88.18 - 90.06) | Buy |
| Bollinger Bands (100): | (87.15 - 89.65) | Buy |
GPCR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 8.5 | Buy |
| Relative Strength Index (14 RSI): | 72.85 | Buy |
| Chaikin Money Flow: | 1903413 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (33.41 - 65.27) | Buy |
| Bollinger Bands (100): | (17 - 45.24) | Buy |
DGRW Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 89.38 | Buy |
| 20-day SMA: | 89.51 | Buy |
| 50-day SMA: | 89.07 | Buy |
| 200-day SMA: | 84.55 | Buy |
| 8-day EMA: | 89.39 | Buy |
| 20-day EMA: | 89.33 | Buy |
| 50-day EMA: | 88.98 | Buy |
| 200-day EMA: | 85.9 | Buy |
GPCR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 64.43 | Buy |
| 20-day SMA: | 52.92 | Buy |
| 50-day SMA: | 40.28 | Buy |
| 200-day SMA: | 26.09 | Buy |
| 8-day EMA: | 64 | Buy |
| 20-day EMA: | 55.88 | Buy |
| 50-day EMA: | 44.22 | Buy |
| 200-day EMA: | 31.26 | Buy |
WisdomTree US Quality Dividend Growth Fund Earnings Growth & DGRW Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Structure Therapeutics, Inc. Earnings Growth & GPCR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.48 per share, and a decrease next year of $0.10 per share.
WisdomTree US Quality Dividend Growth Fund Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Structure Therapeutics, Inc. Technical Analysis
| Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||